CHARLES RIVER LABORATORIES INTERNATIONAL, INC.·4

May 16, 4:35 PM ET

MASSARO GEORGE 4

4 · CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Filed May 16, 2024

Insider Transaction Report

Form 4
Period: 2024-05-15
Transactions
  • Sale

    Common Stock

    2024-05-15$234.72/sh123$28,8716,064 total
  • Sale

    Common Stock

    2024-05-15$235.61/sh113$26,6245,951 total
  • Sale

    Common Stock

    2024-05-15$236.78/sh96$22,7315,855 total
Footnotes (3)
  • [F1]This transaction was executed in multiple trades at prices ranging from $234.27 to $235.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan.
  • [F2]This transaction was executed in multiple trades at prices ranging from $235.35 to $236.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan.
  • [F3]This transaction was executed in multiple trades at prices ranging from $236.36 to $237.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT